AOD-9604 is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications
Oral tofacitinib: contemporary appraisal of its role in dermatology
In clinical trials, patients were treated 3 times, with 6-10 days between each treatment.2 In practice, we find once a week on the same day, for 3 weeks in a row, is the easiest plan for patients to stick to, and sticking to the treatment plan is critical to getting the results Sebacia can create
therefore, its crucial to follow professional medical advice and maintain open communication with your healthcare provider
doi: 10.7326/AITC201901010 123 SmolenJAletahaDBartonABurmesterGEmeryPFiresteinGet al